Is it to early to predict when these discoveries might lead to new brain tumor treatments?
Dr. Barker: Too early. I think it’s too early, but it may be a guide for how to use the therapies we already have. Again, it’s a little early, but if you know that certain pathways are turned off or other pathways are turned on, then you may be able to combine drugs that we already have in different ways. That’s not something that we’ve actually done very well so far because we just haven’t had the data to say that combination is the right combination. So it could produce some short term gains for patients in terms of, you know, how do you combine drugs you already have. In terms of the future, though, I think it’s going to actually lead us in some new directions for therapy. Balintfy: When do you expect results from other studies by the Cancer Genome Atlas Research Network? Dr. Barker: They’re already underway so ovarian cancer, which is another of those cancers that’s very, very hard to diagnose, we’re just started on the characterization of that tumor and squamous cell lung cancer w
